Press release
Central Florida Cancer Institute Achieves National Accreditation as a Breast Center
Davenport, FL, May 13, 2021: The Central Florida Cancer Institute has been granted a three-year, full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC). In 2019, an estimated 268,600 new cases of invasive breast cancer will be diagnosed among women and approximately 2,670 cases will be diagnosed in men. Source: American Cancer SocietyAccreditation by the NAPBC is only granted to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease.
Dr. Randy Heysek, Medical Director and Founder said, “Achieving this prestigious designation by NAPBC is recognition of the extraordinary work of our dedicated team of experienced, compassionate breast cancer experts here at the Central Florida Cancer Institute. Our entire team is dedicated to working together to ensure the best outcomes for our breast cancer patients.”
Dr. Sandra Sha, our expert board-certified radiation oncologist said, “Receiving this accreditation is wonderful news for the Central Florida Cancer Institute and the patients that we take care of every day. Our hallmark of excellence is our care and attention to let our patients know that they are receiving the highest standard of care in Polk County when they seek treatment for breast cancer. It is wonderful news for Central Florida Cancer Institute and the patients we care for every day that we received this accreditation! Our hallmark of excellence is our care and attention to let our breast cancer patients know that they are receiving the highest standard of care!”
The standards include proficiency in the areas of:
• Center leadership
• Clinical management
• Research
• Community outreach
• Professional education and
• Quality improvement.
Who is NAPBC?
The National Accreditation Program for Breast Centers (NAPBC) is the driver for developing quality breast centers across the country. Breast centers with this accreditation meet these standards and actively work as a team to ensure quality breast cancer care in their respective communities.
Receiving care at an NAPBC-accredited center ensures that a patient will have access to:
• Comprehensive care, including a full range of state-of-the-art services
• A multidisciplinary team approach to coordinate the best treatment options
• Information about ongoing clinical trials and new treatment options
• Quality breast care close to home.
/ENDS
10831 Woodchase Circle
About the Central Florida Cancer Institute: The Central Florida Cancer Institute was founded in the year 2000. Two offices, located in Davenport and Lake Wales, offer radiation oncology and general urology services. The medical staff consists of radiation oncologists, a radiologist and urologists providing a multi-disciplinary approach in treating and caring for patients. The center, designed and managed by Dr. Randy Heysek, is staffed with trained medical, clerical and administrative personnel, who are dedicated to the treatment of cancer patients.
For further information please visit our website: https://cfcancerinst.com/ and Facebook page: https://www.facebook.com/CentralFloridaCancerInstitute/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Florida Cancer Institute Achieves National Accreditation as a Breast Center here
News-ID: 2285030 • Views: …
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…